From: In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature
Study | n | Type | tCho SNR method | Sensitivity | Specificity |
---|---|---|---|---|---|
Tse et al. 2003 [50] | 40 | SV | ≥2 malignant | 89% | 100% |
Huang et al. 2004 [6] | 50 | SV | ≥2 malignant | 100% | 67% |
Jacobs et al. 2004 [17] | 15 | MRSI | ≥5 malignant | 87% | 85% |
Bartella et al. 2006 [51] | 57 | SV | ≥2 malignant | 100% | 88% |
Bartella et al. 2007 [52] | 32 | SV | ≥2 malignant | 100% | 85% |
Baek et al. 2008 [8] | 36 | MRSI | >3.2 malignant | 81% | 78% |
Hu et al. 2008 [15] | 9 | MRSI | >3 malignant | 100% | 100% |
Tozaki et al. 2009 [53] | 171 | SV | ≥2 malignant | 44% | 85% |
Danishad et al. 2010 [20] | 25 | MRSI | ≥2 malignant | 100% | NA |
Bathen et al. 2011 [54] | 40 | SV | ≥2 malignant | 60% | NA |